- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02495142
Psychosocial Issues and Bariatric Surgery (LABS3)
Bariatric surgery is associated with long-term weight loss, as well as short-term improvements in obesity-related medical comorbidities. However, a significant proportion of patients fail to lose sufficient weight, or experience significant weight regain. Although no robust predictors of response have been identified, pilot data that will be presented and reviewed suggest that surgery has profound effects on eating behaviors and psychosocial functioning, and that these factors may affect postoperative weight control.
The present investigation capitalizes on the Longitudinal Assessment of Bariatric Surgery (LABS) consortium to conduct an in-depth examination of the psychosocial aspects of surgery among a geographically, ethnically, and racially diverse sample of men and women undergoing bariatric surgery. This project unites experts in the areas of psychopathology, eating behaviors and quality of life to conduct a naturalistic study using state-of-the-art assessment tools; to document the relationships among psychosocial factors; and to examine psychosocial predictors of surgical outcomes.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Primary Objective. Despite the obvious impact of bariatric surgery procedures on intake, no study to date has included a careful assessment of psychological factors, feeding patterns, energy intake and eating problems in this group of patients longitudinally. The Investigators believe that a careful examination of the structure of eating behavior and eating problems (e.g. vomiting) would be very helpful in guiding bariatric surgeons and dieticians who work with this group of patients in terms of dietary advice and recommendations, and with the prediction of eating problems and poor nutrient intake in the subgroup that develops such problems. This study involves prospective assessment of psychosocial outcomes of surgery by adding a supplemental battery to the LABS-2 assessment schedule. Conducting assessments at three of the LABS clinical sites assures the geographic, ethnic, and racial diversity of the sample, and hence enhances the potential to identify a subgroup or subgroups of patients susceptible to poor outcomes after surgery and the generalizability of study results.
This study would also include an evaluation of psychopathological and behavioral variables that might impact on weight loss and weight regain, and psychosocial complications post-operatively, as well as quality of life.
The overall goal of this study is to obtain detailed information that will allow a careful assessment of psychopathology, quality of life and eating behavior pre-surgically and at regular intervals for up to 7 years after the surgical intervention.
The Investigators believe that the instruments and procedures selected will allow a detailed examination of psychopathology, eating pathology and quality of life in detail.
The Investigators believe that the measures and tasks added at year 7 will allow the examination of theories of affect regulation, cognitive control, and reward processing in understanding postsurgical outcomes regarding pathological eating behavior and alcohol/substance use and their shared similarities as well as underlying neurobiological systems.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
North Dakota
-
Fargo, North Dakota, Verenigde Staten, 58103
- Neuropsychiatric Research Institute
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Male and female patients who are at least 18 years of age and undergo bariatric surgery by a LABS certified surgeon.
- Previous enrollment in LABS-1 and LABS-2.
- BMI at baseline of greater than or equal to 35.
Exclusion Criteria:
- Informed consent not obtained
- Type 1 Diabetes Mellitus
- Unlikely to comply with follow-up protocol (ie: geographically inaccessible for study visits)
- Unable to communicate with local study staff
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Psychopathology as measured by the SCID
Tijdsspanne: annually up to 7 years post bariatric surgery
|
Structured Clinical Interview for DSM-IV, Patients Edition (SCID) will be administered to assess comorbid Axis I psychopathology.
|
annually up to 7 years post bariatric surgery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Quality of life as measured by the IWQOL
Tijdsspanne: annually up to 7 years post bariatric surgery
|
Impact of Weight on Quality of Life Questionnaire: This is a 31-item, self-report, obesity-specific quality of life measure that will be utilized to assess quality of life.
|
annually up to 7 years post bariatric surgery
|
|
Change in Quality of life as measured by the SF-36
Tijdsspanne: annually up to 7 years post bariatric surgery
|
ShortForm-36: The SF-36 is a 36-item questionnaire that assesses functioning and quality of life as it relates to health status.
|
annually up to 7 years post bariatric surgery
|
|
Change in Depression as measured by the BDI
Tijdsspanne: annually up to 7 years post bariatric surgery
|
Beck Depression Inventory: The BDI is a 21-item instrument that is widely used to assess depressive symptoms.
|
annually up to 7 years post bariatric surgery
|
|
Change in Eating behaviors as measured by the EDE
Tijdsspanne: annually up to 7 years post bariatric surgery
|
Eating Disorder Examination: The diagnostic version of the EDE will be used as the primary measure of eating behavior and pathology.
|
annually up to 7 years post bariatric surgery
|
|
Change in Impulse Control as measured by the SCID-ICD module
Tijdsspanne: annually up to 7 years post bariatric surgery
|
The impulse control module of the SCID will be administered to assess impulsive/compulsive disorders for participants.
|
annually up to 7 years post bariatric surgery
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Affect regulation as measured by the DERS
Tijdsspanne: 7 year post bariatric surgery
|
Difficulties in Emotion Regulation Scale: The DERS is a 36-item self-report questionnaire that assesses six domains of emotion dysregulation and has been found to have acceptable internal consistency as well as adequate test-retest reliability and construct validity.
|
7 year post bariatric surgery
|
|
Affect regulation as measured by the AIM
Tijdsspanne: 7 years post bariatric surgery
|
Affect Intensity Measure:The AIM is a 40-item self-report measure of positive and negative emotional intensity and reactivity.
|
7 years post bariatric surgery
|
|
Impulsivity
Tijdsspanne: 7 years post bariatric surgery
|
UPPS-P Impulsive Behavior Scale: This is a 59-item self-report measure assessing five dimensions of impulsivity.
Only the negative urgency and positive urgency subscales will be administered.
|
7 years post bariatric surgery
|
|
Behavioral inhibition as measured by the SPSRQ
Tijdsspanne: 7 years post bariatric surgery
|
Sensitivity to Punishment and Sensitivity to Reward Questionnaire: This is a 44-item self-report measure that is based on Gray's behavioral inhibition and activation motivational systems conceptualization, and assesses sensitivity to punishment and reward.
|
7 years post bariatric surgery
|
|
Temperament as measured by the ATQ
Tijdsspanne: 7 years post bariatric surgery
|
Effortful Control Scale of the Adult Temperament Questionnaire: This 19-item self-report measure assesses several components of dispositional effortful control, including attentional control (i.e., ability to voluntarily focus or shift attention), inhibitory control (i.e., ability to inhibit behavior), and activation control (i.e., ability to activate behavior as needed).
|
7 years post bariatric surgery
|
|
Cognitive Control as measured by the Go/No-Go Task
Tijdsspanne: 7 years post bariatric surgery
|
Go/No-Go Task: This computerized task assesses the capacity for suppressing previously reinforced responses.
|
7 years post bariatric surgery
|
|
Cognitive Control as measured by the Delay Discounting Task
Tijdsspanne: 7 years post bariatric surgery
|
Delay Discounting Task: Delay discounting tasks require participants to choose between receiving a larger amount of money after a delay versus receiving a smaller amount immediately.
|
7 years post bariatric surgery
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: James E. Mitchell, MD, Neuropsychiatric Research Institute
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 5R01DK084979-06 (Subsidie/contract van de Amerikaanse NIH)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Depressieve stoornis
-
University of HoustonOnbekend
-
UCB Biopharma SRLNog niet aan het wervenOntwikkelings- en epileptische encefalopathieën | SLC6A1 Neurodevelopmental Disorder (NDD)
-
New York City Health and Hospitals CorporationBeëindigdGlaucoom | Ziekte van het netvlies | Visuele Pathway DisorderVerenigde Staten
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLCAanmelden op uitnodigingMacula ziekte | Visuele Pathway Disorder | Ziekte van de oogzenuwVerenigde Staten
-
Otsuka Pharmaceutical Co., Ltd.WervingAttention-deficit Hyperactivity Disorder (ADHD)Japan
-
Assistance Publique - Hôpitaux de ParisNog niet aan het wervenMajor Depressive Disorder (MDD) met slapeloosheidFrankrijk
-
Otsuka Pharmaceutical Co., Ltd.WervingAttention-deficit Hyperactivity Disorder (ADHD)Japan
-
Fondazione G.B. Bietti, IRCCSVoltooidGlaucoom | Optische neuropathie, ischemische | Optische zenuw | Visuele Pathway Disorder | Neurale geleidingItalië
-
University of MiamiNational Eye Institute (NEI)VoltooidGlaucoom | Maculaire degeneratie | Retinale degeneratie | Optische neuropathie | DrDeramus verdachte | Visuele Pathway DisorderVerenigde Staten
-
Isfahan University of Medical SciencesVoltooidZiekte van Tanger | Body Mass Index Quantitative Trait Locus 5 DisorderIran, Islamitische Republiek